Skinvisible (SKVI) Total Liabilities (2010 - 2026)

Skinvisible (SKVI) has 17 years of Total Liabilities data on file, last reported at $10.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 10.59% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (up 10.59% YoY), and the FY2025 full-year result was $10.4 million, up 10.75% from the prior year.
• Total Liabilities improved to $10.6 million in Q1 2026, from $10.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $10.6 million in Q1 2026 to a low of $5.8 million in Q1 2022.
• A 5-year average of $8.8 million and a median of $9.4 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 43.82% in 2023 and climbed 1.22% in 2025, its largest moves.
• Tracing SKVI's Total Liabilities over 5 years: stood at $6.9 million in 2022, then jumped by 33.37% to $9.2 million in 2023, then rose by 2.13% to $9.4 million in 2024, then increased by 10.75% to $10.4 million in 2025, then climbed by 2.49% to $10.6 million in 2026.
• Business Quant data shows SKVI's Total Liabilities at $10.6 million in Q1 2026, $10.4 million in Q4 2025, and $10.1 million in Q3 2025.